Ioannis Patrikios
Deputy Dean, Professor, Biochemistry
I.Patrikios@euc.ac.cy
22559417
The School of Medicine
Department of Medicine
Academic Qualifications
| Qualification | Year | Awarding Institution | Department | Thesis title (Optional Entry) |
| Ph.D | 1994 | Graduate School and University centre of The City University of New York | Biochemistry | Level 1: Monoclonal Antibodies and Cancer Level 2: Lipid Agglutinins |
| BSc | 1986 | The City University of New York | Biochemistry | |
Employment History
| Employment history in Academic Institutions/Research Centers – List by the three (3) most recent | ||||
| Period of employment | Employer | Location | Position | |
| From | To | |||
| 2013 | date | European University Cyprus | Nicosia-Cyprus | Professor |
| 2005 | 2013 | European University Cyprus (EUC) and PALUPA Medical | Nicosia-Cyprus | Collaborator at EUC and CEO at the PALUP Medical |
| 1999 | 2005 | CING | Nicosia-Cyprus | Senior Visiting Scientist |
Publications
| Year | Title | Other authors | Journal and Publisher / Conference | Vol. | Pages |
| 2019 | U-74389G Significantly Reduced TNF-α in a Swine Model of Acute Liver Ischemia-Reperfusion Injury | Zavridis P, Vlachos G, Lisacek-Kiosoglous A, Georgiou A, Tsitskari M, Constantinos Hadjileontis, Ioannis Patrikios, Apostolos Papalois, George Zografos and Konstantinos Toutouzas | Biochem Physiol | 8 | 248-254 |
| 2019 | Glycogen Storage DiseaseTypesI, II, III and V – A Mini Review | Schmittner Philine, Symvoulidis Panagiotis, Thorisdottir Hildur Maria, Vedsted Tina, and Ioannis Patrikios | Journal of Medical Practice and Review | 3 | 413-425 |
| 2018 | Annonacin promotes selective cancer cell death via NKA-dependent and SERCA-dependent pathways. | Yiallouris A, Patrikios I, Johnson EO, Sereti E, Dimas K, De Ford C, Fedosova NU, Graier WF, Sokratous K, Kyriakou K, Stephanou A. | Cell Death Dis | 9 | 757-764 |
| 2017 | Meeting Report 5th International Multithematic Scientific Bio-Medical Congress, Cyprus 2017 | Ioannis Patrikios; Andrew Georgiou, Anthony Lisacek-Kiosoglous | Cell Death Dis | 9 | 358-363 |
| 2017 | Klotho: The Protein of Faith. EC Neurology | Andrew Georgiou, Anthony Lisacek-Kiosoglous, Andreas Yiallouris, Anastasis Stephanou and Ioannis Patrikios | EC Neurology | 7.5 | 189-223 |
| 2017 | Meeting Report 4th International Multithematic Scientific Bio-Medical Congress, Cyprus 2016 | Ioannis Patrikios; Tassos Stephanou | Cell Death and Disease | 8 | 1-3 |
| 2016 | Multiple Sclerosis in Cyprus: A Fourteen Year (2000-2014) | Elena Charalambidou · Marios Pantzaris · Ioannis Patrikios | American Journal of Epidemiology and Infectious Diseases | 4 | 1-9 |
| 2016 | The neurological patient in the operating room | P. Papagiorgis · I. Patrikios · D. Chaniotis · C. Tsiou | Surg Chron | 21 | 53-63 |
| 2016 | ANTICANCER PROPERTIES OF Na+/K+-ATPase: A MINI REVIEW | Ioannis Patrikios · Andreas Yiallouris · Tassos Stephanou | Asian Journal of Science and Technology | 5 | 2864-2868 |
| 2016 | Graviola: A Systematic Review on Its Anticancer Properties | I. Patrikios, A. Stephanou A. Yiallouris | .American Journal of Cancer Prevention | 6 | 128-131 |
| 2012 | “Composition and methods for treating neurologic disorders.” Patent | I. Patrikios, G Loukaides, M. Pantzaris | PCT Patent No. PCT/IB2012/000824 |
Exhibitions
| Date | Topic | International / Local | Location* | Role in Exhibition |
| SEPTEMBER 2016 | Multiple Sclerosis | International | London | Neuroaspis plp10 (excibit our novel nutraceutcal) for MS therapy |
| November 2016 | Multiple Sclerosis | International | FYROM | Neuroaspis plp10 (excibit our novel nutraceutcal) for MS therapy |
| May 2017 | Multiple Sclerosis Treatment | Local | Bratislava | Neuroaspis plp10 (excibit our novel nutraceutcal) for MS therapy |
| Oct 2018 | International | Berlin | Neuroaspis plp10 (excibit our novel nutraceutcal) for MS therapy |
Research Projects
| Date | Title | Funded by | Project Role* |
| 2019 | Gender net | European Union | Project Coordinator |
| 2018 | COST | European Union | “ |
| 2015 | Phase II clinical trial on Parkinson’s, the DIMENTIA study | Ministry of Commerce Industry and Tourism | “ |
| 2013 | Phase III clinical trial the MINERAL study | Ministry of Commerce Industry and Tourism | “ |
| 2007 | Phase II clinical trial the MINERAL study | Ministry of Commerce Industry and Tourism | “ |
Academic Consulting Services/Councils/Boards/Editorial Committees
| Period | Organization | Title of Position or Service | Key Activities |
| 2013-todate | EUC-School of Medicine | Chairman | Operation of the School of Medicine |
| 2003-2013 | PALUPA Medical Ltd | CEO | Operations of the company |
| 2013- todate | EUC-School of Medicine | Founder and committee chairman | Organizing International Congresses; International Biomedical Scientific Cyprus |
| 2016-todate | EC Neurology | International journal | Editor |
| 2015-todate | Academy of Forensic Medical Sciences | Academic Advisory Board | Advisor |
Awards/International Recognition
| Date | Title | Awarded by: |
| 2015 | Forensic Fellows of Medical Science F.F.M.S. (UK) | Academy of Forensic Medical Sciences. Professor Dr Peter Vanezis |
| 2015 | Recent Experts Speak Interviews | http://www.vitasearch.com/CP/experts/p2experts.htm |
| 2001 | Fellowship | Scuola Superiore d'Immunologia Ruggero Ceppellini, Italy |
| 2001 | appointed at a national level for the European Advisory Council for food Safety and Quality, Food and Biotechnology | Ministry of Commerce, Cyprus Government |
| 1994 | Sigma Xi Honor Society (USA) | By a Rockefeller founded Society |
Other Achievements
| Date | Title | Key Activities: |
| 2015 | Neuroaspis plp10 | A member of the 3 member team founders of a novel nutraceutical for multiple sclerosis that is ever since qxazZin the International market |